A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement
Clinical trial NCT00612534 · COMPLETED
Trial details
- NCT number
- NCT00612534
- Sponsor
- Talphera, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2008-10-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.